
Highlights
Age Groups Seen
- Young Adult 18-25
- Adult 26-64
- Older Adult 65+
Languages
- Punjabi
- Hindi
- English
In-Network Plans
View All Accepted Plans (12)Gender
FemaleJohns Hopkins Affiliations:
- Johns Hopkins School of Medicine Faculty
About Tania Jain
Professional Titles
- Director, Immune Effector Cell Therapy Program, Johns Hopkins University
Primary Academic Title
Associate Professor of Oncology
Johns Hopkins Physician
Background
As a physician scientist in the hematological malignancies and stem cell transplantation division with Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins, my focus is on the various aspects of cellular therapy in the treatment of hematological malignancies. My primary research focus is to develop strategies to prevent relapse of hematological malignancies following allogeneic stem cell transplantation. Additionally, I serve as the director of the adult CAR T program for hematological malignancies as we grow our CAR T program to help patients with advanced hematological malignancies. My academic interest in this space lies in studying the aspects of toxicity of CAR T cell therapy with an aim to improve long term outcomes in these patients. Among hematological malignancies, myeloproliferative disorders are my area of interest and I work to study newer drugs in early phase of development and also its treatment using allogeneic stem cell transplantation.
Patient appointments: 410-955-8893
Centers and Institutes
Find a Clinical Trial
View all trials by this principal investigator.
PubMed - Publications
https://www.ncbi.nlm.nih.gov/myncbi/1BG-wp3PZ1lAp/bibliography/public/
Selected Publications
Jain T, Bar M, Kansagra AJ, Chong EA, Hashmi SK, Neelapu SS, Byrne M, Jacoby E, Lazaryan A, Jacobson CA, Ansell SM, Awan FT, Burns L, Bachanova V, Bollard CM, Carpenter PA, DiPersio JF, Hamadani M, Heslop HE, Hill JA, Komanduri KV, Kovitz CA, Lazarus HM, Serrette JM, Mohty M, Miklos D, Nagler A, Pavletic SZ, Savani BN, Schuster SJ, Kharfan-Dabaja MA, Perales MA, Lin Y. Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy. Biol Blood Marrow Transplant. 2019 Dec;25(12):2305-2321. doi: 10.1016/j.bbmt.2019.08.015. Epub 2019 Aug 22. Review. PubMed PMID: 31446199.
Jain T, Kunze KL, Mountjoy L, Partain DK, Kosiorek H, Khera N, Hogan WJ, Roy V, Slack JL, Noel P, Fauble VDS, Leis JF, Sproat L, Tefferi A, Patnaik MM, Mesa RA, Palmer J. Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis. Blood Cancer J. 2020 Mar 10;10(3):36. doi: 10.1038/s41408-020-0302-9. PubMed PMID: 32157091; PubMed Central PMCID: PMC7064504
Jain T, Kunze KL, Temkit M, Partain DK, Patnaik MS, Slack JL, Khera N, Hogan WJ, Roy V, Noel P, Leis JF, Sproat LZ, Fauble V, Mesa RA, Palmer J. Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis. Bone Marrow Transplant. 2019 Feb;54(2):204-211. doi: 10.1038/s41409-018-0226-1. Epub 2018 May 24. PubMed PMID: 29795431
Jain T, Sauter CS, Shah GL, Maloy MA, Chan J, Scordo M, Avecilla ST, Batlevi Y, Dahi PB, Batlevi CW, Lia Palomba M, Giralt SA, Perales MA. Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma. Leukemia. 2019 Oct;33(10):2540-2544. doi: 10.1038/s41375-019-0476-y. Epub 2019 May 21. PubMed PMID: 31114023
Pennisi M, Jain T, Santomasso BD, Mead E, Wudhikarn K, Silverberg ML, Batlevi Y, Shouval R, Devlin SM, Batlevi C, Brentjens RJ, Dahi PB, Diamonte C, Giralt S, Halton EF, Maloy M, Palomba ML, Sanchez-Escamilla M, Sauter CS, Scordo M, Shah G, Park JH, Perales MA. Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management. Blood Adv. 2020 Feb 25;4(4):676-686. doi: 10.1182/bloodadvances.2019000952. PubMed PMID: 32084260; PubMed Central PMCID: PMC7042979
Honors
- ASBMT Travel Grant Award, American Society of Blood and Marrow Transplantation, 1/1/18
- ASBMT Clinical Research Training Course (CRTC) Scholar Award, American Society of Blood and Marrow Transplantation, 1/1/18
- H Jean Khoury Award for Scholarly Excellence, American Society of Blood and Marrow Transplantation, 1/1/18
- ASH Abstract Achievement Award, American Society of Hematology, 1/1/17
- American Society of Hematology HONORS (Hematology Opportunities for the Next Generation of Research Scientists) Award, 1/1/14
- Kass Award, Infectious Disease Society of America Annual Meeting, 1/1/13
Memberships
- Member, American Society of Hematology
- Member, American Society of Clinical Oncology
- Member, American Society of Transplantation and Cellular Therapy (previously, American Society of Blood and Marrow Transplantation)
Professional Activities
- Adult Chimeric Antigen Receptor T cell Therapy Program for Hematological Malignancies, The Sidney Kimmel Comprehensive Cancer at Johns Hopkins University, Director, 1/1/19
- Committee on Education, American Society of Transplantation and Cellular Therapy, Chair, 1/1/22
- Practice Guidelines Committee, American Society of Transplantation and Cellular Therapy, Member, 1/1/19
Locations
- Sidney Kimmel Comprehensive Cancer Center
- 401 North Broadway Street, Weinberg BLDG, Baltimore, MD 21287
- Get Directions
- phone: 410-955-8964
- fax: 410-367-2194
Expertise
Education
- Fellowship: Memorial Sloan Kettering, 2019
- Fellowship: Mayo Clinic College of Medicine, Hematology and Oncology, 2018
- Residency: Detroit Medical Center, Internal Medicine, 2015
- Medical Education: Government Medical College of Patiala, MBBS, 2009
Insurance
- Aetna
- CareFirst
- Cigna
- First Health
- Geisinger Health Plan
- HealthSmart/Accel
- Johns Hopkins Health Plans
- MultiPlan
- Pennsylvania's Preferred Health Networks (PPHN)
- Point Comfort Underwriters
- Private Healthcare Systems (PHCS)
- Veteran Affairs Community Care Network (Optum-VACCN)
Ratings & Reviews
4.9 out of 5
89 ratings, 42 reviewsThe Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
- 5 out of 5 starsReviewed on 2/18/2026
Dr. Jain has strong expertise in her speciality and is well-respected. Further, she seems compassionate and thoughtful in her delivery of care. Johns Hopkin is fortunate to have her among its medical providers.
- 5 out of 5 starsReviewed on 2/17/2026
Great
- 5 out of 5 starsReviewed on 2/17/2026
Caring doctor who listens
- 5 out of 5 starsReviewed on 2/11/2026
Dr. Jain is a trusted advisor given her extensive knowledge about the rare condition that I have.
- 5 out of 5 starsReviewed on 2/10/2026
Excellent
- 5 out of 5 starsReviewed on 2/10/2026
Dr. Jain is AMAZING! She is concerned about my health and also my quality of life. She is made living with cancer, much more tolerable.
- 5 out of 5 starsReviewed on 1/22/2026
Very knowledgeable and thorough.
- 5 out of 5 starsReviewed on 1/22/2026
Dr Jain is amazing
- 5 out of 5 starsReviewed on 1/13/2026
Good
- 5 out of 5 starsReviewed on 1/13/2026
Continuing excellent session
- 5 out of 5 starsReviewed on 1/13/2026
Dr Jain is great overall and perfect for me since she is an expert with my condition
- 4 out of 5 starsReviewed on 1/13/2026
Dr Jain is wonderful
- 5 out of 5 starsReviewed on 1/6/2026
She was wonderful. Listen and provided lots of information
- 5 out of 5 starsReviewed on 1/6/2026
She was great!
- 5 out of 5 starsReviewed on 12/19/2025
Dr. Jain has recommended an oral chemo that has greatly assisted in the treatment of my myelofibrosis. She has followed up to make sure the treatment continues to be effective. While I am only seeing her about twice a year (as I have a local oncologist), she is always available through the portal to respond to my concerns.
- 5 out of 5 starsReviewed on 11/25/2025
Dr.Tania Jain always takes the time to give me detailed answers to my questions. She also does an amazing job helping me plan for the future.
- 5 out of 5 starsReviewed on 11/25/2025
Good experience to date
- 5 out of 5 starsReviewed on 11/11/2025
Knowledgeable. Helpful.
- 4 out of 5 starsReviewed on 11/4/2025
Knowledgeable, patient
- 5 out of 5 starsReviewed on 11/4/2025
Dr Jain excellent
- 5 out of 5 starsReviewed on 10/14/2025
Dr Jain is the best / always goes extra mile to go over everything
- 5 out of 5 starsReviewed on 10/7/2025
My slew of appointment this year have been the best medical experience I've had my entire life. Very impressed with Hopkins. Dr Jain is a stellar doctor and a great communicator. The level to which she adds my concerns to all the decisions we make is something I haven't experienced until now. I believe she is how all doctors should act. And I've had dozens and dozens and dozens of doctors in my journey.
- 5 out of 5 starsReviewed on 9/23/2025
Very Good
- 5 out of 5 starsReviewed on 9/9/2025
She seems very smart and wants the best for me.
- 5 out of 5 starsReviewed on 9/2/2025
Excellent
- 5 out of 5 starsReviewed on 9/2/2025
Dr Jain was very professional, engaged, interested, helpful! I was so glad to have the opportunity to meet with her as her reputation among hematologists I consultvwith is very good.
- 5 out of 5 starsReviewed on 9/2/2025
Dr Jain is amazing. She shows great concern for not only my cancer needs but for my overall health and quality of life.
- 5 out of 5 starsReviewed on 8/27/2025
Great
- 5 out of 5 starsReviewed on 8/26/2025
Liked her. Explained things so I could understand and took time to talk to me. Made good eye contact.
- 5 out of 5 starsReviewed on 8/19/2025
Dr. Jain and [staff] were both very knowledgable and informative during our visit.
- 5 out of 5 starsReviewed on 8/19/2025
This was only my second visit, but so far I am happy with Dr. Jain.
- 5 out of 5 starsReviewed on 8/15/2025
Dr. Jain has been wonderful!
- 5 out of 5 starsReviewed on 7/29/2025
Dr. Jain saved my mother's life by diagnosing her and providing a treatment plan for her incurable leukemia and we are forever grateful.
- 5 out of 5 starsReviewed on 7/29/2025
Dr Jain is a specialist in systemic mastocytosis, a rare condition with which other providers do not have her level of knowledge. I feel that I'm getting the very best advice and care.
- 5 out of 5 starsReviewed on 7/22/2025
Excellent rapport with provider. Felt like part of the care team. Looking forward to continued care
- 5 out of 5 starsReviewed on 7/1/2025
She took time to explain my condition in way that was easy to understand. She also mapped out treatment options and the suggested next steps.
- 5 out of 5 starsReviewed on 7/1/2025
Excellent doctor and care
- 5 out of 5 starsReviewed on 7/1/2025
Dr. Jain and [staff] always take their time with me and make me feel heard. I never feel rushed and I feel like they truly care about me and my health.
- 5 out of 5 starsReviewed on 6/24/2025
Excellent
- 5 out of 5 starsReviewed on 6/10/2025
My experience with Dr. Jain was outstanding. She was caring and compassionate and thoughtful in her care for me. I highly recommend as well as the office.
- 4 out of 5 starsReviewed on 5/21/2025
Provider is great.
- 5 out of 5 starsReviewed on 4/22/2025
I was touched that Dr. Jain came out to the waiting room to get me as well as walked me to reception to coordinate my lab work